Healthcare
Live Price
Offline$16.29
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 255 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sugi Holdings Co.,Ltd. (SGIPF) is a Healthcare stock with a market cap of $563.91B and listed on OTC. The stock last traded around $16.29 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +15.4%, EPS growth of +75.3%, a dividend yield of 1.1%. What stands out right now is revenue +15.4%, EPS +75.3%, free cash flow +485.7% with operating margin 4.8% and ROIC 11.8%. The dividend is present but secondary, with a yield around 1.1%. Valuation is more restrained than many high-expectation growth names at P/E 12.5 and price/sales 0.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SGIPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SGIPF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SGIPF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SGIPF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$5.7B
+4.0% YoY
FY Net Income
$198.2M
+17.6% YoY
Free Cash Flow
$117.0M
+183.0% YoY
Revenue Growth
+15.4%
EPS Growth
+75.3%
Gross Margin
31.8%
Net Margin
4.5%
Income statement
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 878.0B | 744.5B | 4.9B | 5.4B | 5.7B |
| Gross Profit | 275.0B | 228.8B | 1.5B | 1.7B | 1.7B |
| Operating Income | 42.6B | 36.6B | 232M | 279M | 320M |
| EBITDA | 56.2B | 46.2B | 44.0B | 43.4B | 43.6B |
| Net Income | 25.7B | 22.0B | 139M | 169M | 198M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 52.8B | 43.4B | 254M | 294M | 524M |
| Total Assets | 495.1B | 390.6B | 2.6B | 2.9B | 3.3B |
| Total Liabilities | 244.4B | 157.2B | 1.0B | 1.1B | 1.4B |
| Shareholder Equity | 250.7B | 233.4B | 1.6B | 1.9B | 1.9B |
| Total Debt | 45.4B | 837M | 14M | 20M | 22M |
| Net Debt | -7.4B | -42.6B | -240M | -274M | -502M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
319M
+412.0% YoY
Capital Expenditures
202M
+0.4% YoY
Free Cash Flow
117M
+183.0% YoY
Key ratios
Gross Margin
31.8%
Operating Margin
4.8%
Net Margin
4.5%
ROE
16.1%
Debt / Equity
0.32x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.